SN

Sahm Nasseri

Senior Vice President, Business Development and Strategy

Generate Biomedicines

Generate Biomedicines Pipeline

DrugIndicationPhase
GB-0895Severe AsthmaPhase 3
GB-4362Various in combo with MMAE ADCsPreclinical
GB-5267Metastatic Ovarian CancerPreclinical